Back to search
Intermediate-to-High-Risk Mantle Cell Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intermediate-to-High-Risk Mantle Cell Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intermediate-to-High-Risk Mantle Cell Lymphoma trials you may qualify forThis phase I/II trial studies the side effects and best dose of genetically engineered lymphocyte therapy and to see how well it works after peripheral blood st…
A Single-Arm, Prospective Clinical Study Evaluating the Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined with Obinutuzumab in the First-Line Treatment…